Health MKSAP 18 Audio Companion Part A 06 Rheumatology

top
back
01-01 Introduction to Rheumatology Section.mp3
01-02 Approach to the Patient with Rheumatologic Disease.mp3
01-03 The Musculoskeletal Examination.mp3
01-04 Session MCQ Item 20 An 85-year-old Woman is Evaluated for Left Knee Pain.mp3
01-05 Arthritis.mp3
01-06 Extra-Articular Manifestations of Rheumatologic Disease.mp3
01-07 Session MCQ Item 28 A 43-year-old Woman has Left Knee Pain and Swelling.mp3
01-08 Dermatologic Manifestations of Rheumatologic Disease.mp3
01-09 Ocular Manifestations of Systemic Inflammatory Disease.mp3
01-10 Internal Organ Involvement.mp3
01-11 Laboratory Studies.mp3
01-12 Session 1 Key Points.mp3
01-13 Close to Session 1.mp3
02-01 Introduction to Session 2.mp3
02-02 Complement and Autoantibody Tests.mp3
02-03 Autoantibodies in Rheumatologic Disease.mp3
02-04 Session MCQ Item 35 A 73-year-old Woman is Evaluated for Osteoarthritis.mp3
02-05 Imaging Studies.mp3
02-06 Joint Aspiration.mp3
02-07 Principles of Therapeutics.mp3
02-08 NSAIDs.mp3
02-09 Session MCQ Item 37 A 49-year-old Woman is Evaluated for Worsening Joint Symptoms.mp3
02-10 Colchicine.mp3
02-11 Analgesics and Pain Pathway Modulators.mp3
02-12 Session 2 Key Points.mp3
02-13 Close to Session 2.mp3
03-01 Introduction to Session 3.mp3
03-02 Disease-Modifying Antirheumatic Drugs.mp3
03-03 Nonbiologic DMARDs.mp3
03-04 Session MCQ Item 40 A 21-year-old Woman is Evaluated for Worsening Rash and Arthritis.mp3
03-05 Biologic DMARDs.mp3
03-06 Other Biologic Disease-Modifying Antirheumatic Drugs.mp3
03-07 Session MCQ Item 42 A 32-year-old Woman is Evaluated for Dry Eyes and Dry Mouth.mp3
03-08 Urate-Lowering Therapy.mp3
03-09 Rheumatologic Medications and Pregnancy.mp3
03-10 Vaccination and Screening in Immunosupression.mp3
03-11 Session 3 Key Points.mp3
03-12 Close to Session 3.mp3
04-01 Introduction to Session 4.mp3
04-02 Nonpharmacologic Measures To Address Pain.mp3
04-03 Rheumatoid Arthritis.mp3
04-04 Diagnosis.mp3
04-05 Session MCQ Item 43 A 67-year-old Woman is Seen for Severe Rheumatoid Arthritis.mp3
04-06 Consequences of Persistent Inflammation.mp3
04-07 Laboratory and Imaging Studies.mp3
04-08 Complications and Extra-Articular Manifestations.mp3
04-09 Session MCQ Item 54 A 30-year-old Woman is Evaluated for Pain and Swelling of the PIP Joints.mp3
04-10 Management.mp3
04-11 Disease-Modifying Antirheumatic Drugs.mp3
04-12 Session 4 Key Points.mp3
04-13 Close to Session 4.mp3
05-01 Introduction to Session 5.mp3
05-02 Pathophysiology of Osteoarthritis.mp3
05-03 Classification.mp3
05-04 Session MCQ Item 64 A 55-year-old Man is Evaluated for Progressive Joint Pain.mp3
05-05 Diffuse Idiopathic Skeletal Hyperostosis.mp3
05-06 Diagnosis.mp3
05-07 Laboratory and Imaging Studies.mp3
05-08 Session MCQ Item 75 A 53-year-old Woman is Evaluated for Sensory Loss in the Hands.mp3
05-09 Management.mp3
05-10 Pharmacologic Therapy.mp3
05-11 Fybromyalgia.mp3
05-12 Management.mp3
05-13 Session 5 Key Points.mp3
05-14 Close to Session 5.mp3
06-01 Introduction to Session 6.mp3
06-02 Spondyloarthritis.mp3
06-03 Classification of Spondyloarthritis.mp3
06-04 Session MCQ Item 88 A 40-year-old Woman is Evaluated for Inflammatory Arthritis.mp3
06-05 Ankylosing Spondylitis and Psoriatic Arthritis.mp3
06-06 Inflammatory Bowel Disease-Related Arthritis.mp3
06-07 Diagnosis.mp3
06-08 Session MCQ Item 95 A 48-year-old Man is Evaluated for Gout.mp3
06-09 Management.mp3
06-10 Session 6 Key Points.mp3
06-11 Close to Session 6.mp3
07-01 Introduction to Session 7.mp3
07-02 Systemic Lupus Erythematosis.mp3
07-03 Clinical Manifestations.mp3
07-04 Kidney Involvement.mp3
07-05 Cardiovascular and Pulmonary Involvement.mp3
07-06 Hematologic and Gastrointestinal Involvement.mp3
07-07 Association with Malignancy.mp3
07-08 Diagnosis.mp3
07-09 Laboratory Studies.mp3
07-10 Differential Diagnosis.mp3
07-11 Management.mp3
07-12 Session 7 Key Points.mp3
07-13 Close to Session 7.mp3
08-01 Introduction to Session 8.mp3
08-02 Pregnancy and Childbirth Issues.mp3
08-03 Sjogren Syndrome.mp3
08-04 Diagnosis of Sjogrens Syndrome.mp3
08-05 Management.mp3
08-06 Inflammatory Myopathies.mp3
08-07 Epidemiology and Pathophysiology of Inflammatory Myopathies.mp3
08-08 Polymyositis.mp3
08-09 Dermatomyositis.mp3
08-10 Inflammatory Myopathies and Malignancy.mp3
08-11 Diagnosis.mp3
08-12 Session 8 Key Points.mp3
08-13 Close to Session 8.mp3
09-01 Introduction to Session 9.mp3
09-02 Imaging.mp3
09-03 Management and Prognosis.mp3
09-04 Systemic Sclerosis.mp3
09-05 Common Features of the Scleroderma Spectrum Disorders.mp3
09-06 Clinical Manifestations and Diagnosis.mp3
09-07 Cutaneous Involvement.mp3
09-08 Musculoskeletal Involvement.mp3
09-09 Vascular Involvement.mp3
09-10 Kidney and Lung Involvement.mp3
09-11 Session 9 Key Points.mp3
09-12 Close to Session 9.mp3
10-01 Introduction to Session 10.mp3
10-02 Management.mp3
10-03 ACE Inhibitors.mp3
10-04 Mixed Connective Tissue Disease.mp3
10-05 Comparison of MCTD, UCT and Overlap Syndromes.mp3
10-06 Clinical Manifestations and Diagnosis.mp3
10-07 Crystal Arthropathies.mp3
10-08 Epidemiology and Pathophysiology of Gout.mp3
10-09 Causes of Hyperuricemia.mp3
10-10 Acute Gouty Arthritis.mp3
10-11 Intercritical Gout.mp3
10-12 Chronic Recurrent and Tophaceous Gout.mp3
10-13 Diagnosis.mp3
10-14 Pseudogout.mp3
10-15 Session 10 Key Points.mp3
10-16 Close to Session 10.mp3
11-01 Introduction to Session 11.mp3
11-02 Management of Gout.mp3
11-03 Urate-Lowering Therapy.mp3
11-04 Calcium Pyrophosphate Deposition.mp3
11-05 Clinical Manifestations and Diagnosis.mp3
11-06 Management.mp3
11-07 Infectious Arthritis.mp3
11-08 Laboratory and Imaging Studies.mp3
11-09 Infection with Gram-Positive Organisms.mp3
11-10 Disseminated Gonococcal Infection.mp3
11-11 Session 11 Key Points.mp3
11-12 Close to Session 11.mp3
12-01 Introduction to Session 12.mp3
12-02 Mycobacterium Tuberculosis.mp3
12-03 Viral Infections.mp3
12-04 Parvovirus B19.mp3
12-05 Prosthetic Joint Infections.mp3
12-06 Management.mp3
12-07 Systemic Vasculitis.mp3
12-08 Giant Cell Arteritis.mp3
12-09 Management.mp3
12-10 Polymyalgia Rheumatica.mp3
12-11 Takayasu Arteritis.mp3
12-12 Session 12 Key Points.mp3
12-13 Close to Session 12.mp3
13-01 Introduction to Session 13.mp3
13-02 Polyarteritis Nodosa.mp3
13-03 Primary Angiitis of the Central Nervous System.mp3
13-04 Kawasaki Disease.mp3
13-05 ANCA-Associated Vasculitis.mp3
13-06 Clinical Features of ANCA-Associated Vasculitis Disease.mp3
13-07 Granulomatosis with Polyangiitis.mp3
13-08 Microscopic Polyangiitis.mp3
13-09 Eosiophilic Granulomatosis with Polyangiitis.mp3
13-10 Immune Complex-Mediated Vasculitis.mp3
13-11 Cryoglobulinemic Vasculitis.mp3
13-12 IgA Vasculitis and Hypersensitivity Vasculitis.mp3
13-13 Session 13 Key Points.mp3
13-14 Close to Session 13.mp3
14-01 Introduction to Session 14.mp3
14-02 Other Rheumatologic Diseases.mp3
14-03 Relapsing Polychondritis.mp3
14-04 Adult-Onset Still Disease.mp3
14-05 Autoinflammatory Disease.mp3
14-06 Sarcoidosis.mp3
14-07 Genetic Diseases of Connective Tissue.mp3
14-08 IgG4-Related Disease.mp3
14-09 Session 14 Key Points.mp3
14-10 Close to Rheumatology Section.mp3

Total: 943.44 MB (989,271,318 Bytes) in: 179 File(s)